sparfloxacin has been researched along with Leprosy, Cutaneous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, GP; Chavez, VE; Franzblau, SG; Garcia-Ignacio, BY; Jimenez, CL; Livelo, JB; Parrilla, ML | 1 |
| Ishii, N; Nakajima, H; Suga, C; Sugita, Y | 1 |
1 trial(s) available for sparfloxacin and Leprosy, Cutaneous
| Article | Year |
|---|---|
Clinical trial of sparfloxacin for lepromatous leprosy.
Topics: Adolescent; Adult; Animals; Anti-Infective Agents; Antigens, Bacterial; Female; Fluoroquinolones; Foot; Glycolipids; Humans; Leprosy, Lepromatous; Male; Mice; Middle Aged; Mycobacterium leprae; Oxidation-Reduction; Palmitic Acid; Palmitic Acids; Quinolones; Spirometry | 1994 |
1 other study(ies) available for sparfloxacin and Leprosy, Cutaneous
| Article | Year |
|---|---|
A case of relapsed leprosy successfully treated with sparfloxacin.
Topics: Adult; Anti-Infective Agents; Fluoroquinolones; Humans; Leprosy, Lepromatous; Male; Quinolones; Recurrence; Remission Induction | 1996 |